1. Mr. Ghassan Hasbany And his accompanied guests At
Under the patronage of
Mr. Ghassan Hasbany
H.E. the Deputy Prime Minister & Minister of Public Health Lebanon
And his accompanied guests At
Beirut International Healthcare Forum
10th July ,2017
only dominated by international companies leaving all the 327 Arab pharmaceutical companies competing in more or less the same products portfolio
Life saving
Future
Inly us
We know how
Reduce the bill
Investing in the Pharmaceutical Industry in Lebanon , why
By: Abdul Razzaq Yousef
President , Arwan

2. Arwan
Assured Reliability When Absolutely Needed
…One of the most advanced Biotech manufacturing facilities in the MENA and Africa
only dominated by international companies leaving all the 327 Arab pharmaceutical companies competing in more or less the same products portfolio
Life saving
Future
Inly us
We know how
Reduce the bill
Abdul Razzaq Yousef
President
Arwan

3. Arwan investment as of January 2017 88,300,000 Establishment Expenses
8,800,000
Land
7,000,000
Building
15,500,000
Electo mechanical
9,500,000
Industrial Machines & Lab Tools
18,500,000
Products
9,000,000
Goodwill
20,000,000
Total investment in USD $
88,300,000
only dominated by international companies leaving all the 327 Arab pharmaceutical companies competing in more or less the same products portfolio
Life saving
Future
Inly us
We know how
Reduce the bill

4. Mena region ; total market is estimated 27 billion $
Pharmaceutical market in the target countries
Mena region ; total market is estimated 27 billion $
Lebanon is 1.3 billion
Africa ; total market 36 billion $
Central Asia ; total market 48 billion $
Total pharmaceutical market for the targeted countries is 111 billion $ with 15 % growth and about 40 % local manufacturing. Example Lebanon 7% Saudi 25 % Iraq 5% Syria 84 % Egypt 92 % libya 0 % Nigeria 8 % etc
only dominated by international companies leaving all the 327 Arab pharmaceutical companies competing in more or less the same products portfolio
Life saving
Future
Inly us
We know how
Reduce the bill

5. Our target countries
Mena region ; Lebanon , Iraq ,Syria, Jordan ,Saudi , Kuwait , UAE, Bahrain , Oman , Qatar
Africa ; Nigeria , Kenya , Cameroon , Gabon , Batswana , Mauritius , Sudan ,Yemen , Egypt , libya
Central Asia ; Russia ,Kazakhstan, Tajikistan ,Afghanistan , Turkmenistan
Total 25 countries
By 2020
only dominated by international companies leaving all the 327 Arab pharmaceutical companies competing in more or less the same products portfolio
Life saving
Future
Inly us
We know how
Reduce the bill

6. Arwan has a defined strategy for 2020:
Arwan to export to 25 countries by 2020 its products that are Made in Lebanon, and achieve a total sales of 148 million $
only dominated by international companies leaving all the 327 Arab pharmaceutical companies competing in more or less the same products portfolio
Life saving
Future
Inly us
We know how
Reduce the bill

7. Our sales target 2020 2020 Sales assumptions USD $
Gulf & Arab Countries
53,500,000
Africa
52,350,000
CIS & Russia Countries
42,500,000
Total
148,350,000
only dominated by international companies leaving all the 327 Arab pharmaceutical companies competing in more or less the same products portfolio
Life saving
Future
Inly us
We know how
Reduce the bill

8. Investing in the Pharmaceutical Industry in Lebanon : why ?
Working staff for the Industry including pharmacists, chemists and engineers are available in Lebanon from high ranking universities
Prices of local products support exportation
Central Bank of Lebanon supports investment through subsidized loans up to 10 million $
The support of IDAL through the investment package which includes many privileges most important being tax exemption for 10 years
only dominated by international companies leaving all the 327 Arab pharmaceutical companies competing in more or less the same products portfolio
Life saving
Future
Inly us
We know how
Reduce the bill

9. Investing in the Pharmaceutical Industry in Lebanon : why ?
6. Lebanon is an open market for the industry and therefore for export in addition to the easy access via the airport and sea ports
7. Lebanon has open air facility for visitors to visit from different countries
8. Lebanon is a touristic country where historical places , beaches , mountains , restaurants are supportive to the industry .
9. Lebanon is multi ethnical and political that facilitates different nationalities to visit freely .
only dominated by international companies leaving all the 327 Arab pharmaceutical companies competing in more or less the same products portfolio
Life saving
Future
Inly us
We know how
Reduce the bill

10. Investing in the Pharmaceutical Industry in Lebanon : why ?
10. Lebanon is one of the leaders in the region in medical tourism
11. Advanced hospitals in the region that are reference in the use of local products
12. High Caliber, research-oriented Lebanese doctors who are well recognized in the region and even worldwide give credibility to local products once they use them
All the above points will support pharmaceutical products Made in Lebanon and pave their way in the export markets.
only dominated by international companies leaving all the 327 Arab pharmaceutical companies competing in more or less the same products portfolio
Life saving
Future
Inly us
We know how
Reduce the bill

11. Abdul Razzaq Yousef
President